Table 3.
Different subgroups of positive head and neck squamous cell carcinoma patients based on the location of their tumor, the number of patients in the group, the total number of positive slices within the group, and median sensitivity (%) computed from the predictions of the primary test sets during the 30 iteration rounds. Values higher than the overall sensitivity in the primary test sets for the given model (see Table 1) are written in bold.
| HNSCC tumor location | Patients | Slices in total | Non-augmented shallow | Augmented shallow | Non-augmented deep | Augmented deep |
|---|---|---|---|---|---|---|
| Oral cavity | 18 | 203 | 81.7 | 70.4 | 78.3 | 75.0 |
| Root of tongue | 11 | 132 | 96.8 | 86.7 | 97.7 | 83.3 |
| Oropharynx (exc. root of tongue) | 13 | 141 | 50.8 | 33.3 | 51.1 | 35.4 |
| Nasopharynx | 8 | 83 | 33.3 | 26.1 | 39.4 | 45.2 |
| Larynx | 7 | 54 | 65.8 | 73.7 | 73.7 | 77.0 |
| Fossa piriformis | 5 | 90 | 86.7 | 80.5 | 93.3 | 80.2 |
| Unknown primary | 13 | 147 | 90.6 | 88.5 | 90.6 | 88.5 |
| Other | 14 | 145 | 50.0 | 55.8 | 55.2 | 67.7 |